Profile
Kirk D.
Schumacher worked as the General Counsel, SVP-Legal Affairs & Compliance at Seagen Inc. from 2014 to 2014.
Prior to that, he was a Senior Attorney at Venture Law Group and the Principal at Kds Law Group.
He also served as the Senior Vice President & General Counsel at Chinook Therapeutics, Inc. Mr. Schumacher holds a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Wisconsin.
Former positions of Kirk D. Schumacher
Companies | Position | End |
---|---|---|
CHINOOK THERAPEUTICS, INC. | General Counsel | 2023-08-31 |
SEAGEN INC. | Compliance Officer | 2014-11-25 |
Kds Law Group | Corporate Officer/Principal | - |
Venture Law Group
Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Training of Kirk D. Schumacher
University of Wisconsin | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Venture Law Group
Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Commercial Services |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Kds Law Group |
- Stock Market
- Insiders
- Kirk D. Schumacher